Gilmartin Capital LLC
Venture capitalLarkspur · Series A–Late Stage · 2 people tracked
Investment thesis
Gilmartin Capital invests in companies advancing platforms that address large or underserved diseases, technologies that accelerate scientific discovery, and solutions improving the cost, site, and delivery of care. The firm targets opportunities beyond proof of concept that are positioned for meaningful development and growth across the medical device, life science tool, diagnostic, and digital health sectors. Emphasizing insight over capital, Gilmartin offers domain expertise in strategy, market assessment, and capital markets advisory, drawing on a proprietary network of key opinion leaders and operators built over two decades. Much of its fund capital comes from healthcare operators.
Source: firm website, verified Aug 18, 2026.
Team · 2 people
from the firm's websiteWhat they invest in
from 2 of 2 portfolio companiesAI & Machine Learning ×1Biotech ×1EdTech ×1Enterprise Software ×1Future of Work ×1Healthtech ×1Medical Devices ×1
HQs:United States×2
Investments · 2 tracked
founders shown can be your intro pathGalvanize provides customized technical education and training programs to help enterprise teams build skills in AI, machine learning, XP and Agile practices, data pipelines, and cloud operations.
AI & Machine LearningEdTechEnterprise SoftwareFuture of WorkDenver, US
Christopher C. Onan(Executive Officer)James Deters(President and Chief Executive Officer)Lawrence Mandes(Managing Director, New Markets)Tatiana Goldstein(Director)
BoardDaniel Pianko(Director)Jerrold Miller(Director)
Co-investorsTeamworthy VenturesThe Colorado Impact FundVTF CapitalAlly Bridge GroupCatalyst InvestorsFidelity Investments+5 more
Galvanize Therapeutics develops surgical ablation technology using its proprietary Aliya Pulsed Electric Field (PEF) energy to destroy soft tissue cells through regulated cell death mechanisms.
BiotechHealthtechMedical DevicesRedwood City, US
Doug Godshall(Executive Officer, Director)Steve Anheier(Executive Officer)
BoardJonathan Waldstreicher(Executive Officer)Antoine Papiernik(Director)inSeth Harrison(Director)Zack Scott(Director)
Co-investorsNorwest Venture PartnersAlly Bridge GroupATPFidelity InvestmentsJanus Henderson InvestorsPerceptive Xontogeny Venture+2 more
Portfolio news
latest coverage across their companies
Galvanize · muonspace.com · Aug 20, 2026
Galvanize Therapeutics · fiercebiotech.com · Sep 4, 2025
Frequently asked questions
- What stage does Gilmartin Capital LLC invest at?
- Gilmartin Capital LLC invests at the Series A, Series B, Growth, Late Stage stages.
- What sectors does Gilmartin Capital LLC focus on?
- Gilmartin Capital LLC focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Gilmartin Capital LLC located?
- Gilmartin Capital LLC is headquartered in Larkspur, US.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.
The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.


